BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15652949)

  • 1. Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves.
    LeMaire SA; Wang X; Wilks JA; Carter SA; Wen S; Won T; Leonardelli D; Anand G; Conklin LD; Wang XL; Thompson RW; Coselli JS
    J Surg Res; 2005 Jan; 123(1):40-8. PubMed ID: 15652949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase expression in the ascending aorta and aortic valve.
    Wilton E; Bland M; Thompson M; Jahangiri M
    Interact Cardiovasc Thorac Surg; 2008 Feb; 7(1):37-40. PubMed ID: 18025061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
    Ikonomidis JS; Jones JA; Barbour JR; Stroud RE; Clark LL; Kaplan BS; Zeeshan A; Bavaria JE; Gorman JH; Spinale FG; Gorman RC
    J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1028-36. PubMed ID: 17382648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.
    Koullias GJ; Korkolis DP; Ravichandran P; Psyrri A; Hatzaras I; Elefteriades JA
    Eur J Cardiothorac Surg; 2004 Dec; 26(6):1098-103. PubMed ID: 15541969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
    Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
    Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves.
    Boyum J; Fellinger EK; Schmoker JD; Trombley L; McPartland K; Ittleman FP; Howard AB
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):686-91. PubMed ID: 15001896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated expressions of osteopontin and tenascin C in ascending aortic aneurysms are associated with trileaflet aortic valves as compared with bicuspid aortic valves.
    Majumdar R; Miller DV; Ballman KV; Unnikrishnan G; McKellar SH; Sarkar G; Sreekumar R; Bolander ME; Sundt TM
    Cardiovasc Pathol; 2007; 16(3):144-50. PubMed ID: 17502243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase 8 (neutrophil collagenase) in the pathogenesis of abdominal aortic aneurysm.
    Wilson WR; Schwalbe EC; Jones JL; Bell PR; Thompson MM
    Br J Surg; 2005 Jul; 92(7):828-33. PubMed ID: 15918165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases, their tissue inhibitors, and osteopontin in the wall of thoracic and abdominal aortas with dilatative pathology.
    Lesauskaite V; Epistolato MC; Castagnini M; Urbonavicius S; Tanganelli P
    Hum Pathol; 2006 Aug; 37(8):1076-84. PubMed ID: 16867871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of deletion of the tissue inhibitor of matrix metalloproteinases-1 gene on the progression of murine thoracic aortic aneurysms.
    Ikonomidis JS; Gibson WC; Butler JE; McClister DM; Sweterlitsch SE; Thompson RP; Mukherjee R; Spinale FG
    Circulation; 2004 Sep; 110(11 Suppl 1):II268-73. PubMed ID: 15364874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential protein kinase C isoform abundance in ascending aortic aneurysms from patients with bicuspid versus tricuspid aortic valves.
    Jones JA; Stroud RE; Kaplan BS; Leone AM; Bavaria JE; Gorman JH; Gorman RC; Ikonomidis JS
    Circulation; 2007 Sep; 116(11 Suppl):I144-9. PubMed ID: 17846295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of matrix metalloproteinase 2 within the aneurysmal and normal aortic wall.
    Crowther M; Goodall S; Jones JL; Bell PR; Thompson MM
    Br J Surg; 2000 Oct; 87(10):1391-400. PubMed ID: 11044166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
    Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
    Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
    Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
    Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen and elastin degradation by matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in aortic dissection.
    Ishii T; Asuwa N
    Hum Pathol; 2000 Jun; 31(6):640-6. PubMed ID: 10872655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ascending aortic aneurysms in unicommissural aortic valve disease.
    Butany J; Vaideeswar P; Dixit V; Lad V; Vegas A; David TE
    Cardiovasc Pathol; 2009; 18(1):11-8. PubMed ID: 18402825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome.
    Segura AM; Luna RE; Horiba K; Stetler-Stevenson WG; McAllister HA; Willerson JT; Ferrans VJ
    Circulation; 1998 Nov; 98(19 Suppl):II331-7; discussion II337-8. PubMed ID: 9852923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of matrix metalloproteinases and their tissue inhibitor of metalloproteinases in myxomatous change of cardiac floppy valves.
    Togashi M; Tamura K; Nitta T; Ishizaki M; Sugisaki Y; Fukuda Y
    Pathol Int; 2007 May; 57(5):251-9. PubMed ID: 17493172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms.
    Schmoker JD; McPartland KJ; Fellinger EK; Boyum J; Trombley L; Ittleman FP; Terrien C; Stanley A; Howard A
    J Thorac Cardiovasc Surg; 2007 Jan; 133(1):155-61. PubMed ID: 17198804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of matrix metalloproteinase-9 in abdominal aortic aneurysms.
    Yamashita A; Noma T; Nakazawa A; Saito S; Fujioka K; Zempo N; Esato K
    World J Surg; 2001 Mar; 25(3):259-65. PubMed ID: 11343173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.